New in MMWR: Foodborne Illness Surveillance, Xylazine Use, and more

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



MMWR banner

July 4, 2024

In this Issue

WEEKLY REPORT

The graphic shows illustrations of drugs with text about a new CDC report on xylazine use among adults.

Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment

Among adults reporting fentanyl or heroin use recently or as their primary lifetime substance use problem, past nonfatal overdoses were more often reported among those reporting xylazine use than those who did not report xylazine use.

PDF of this issue (link)

CONTINUING EDUCATION

This image is of a mother holding her infant while speaking to a clinician.

New MMWR Medscape CE on CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux